We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

109 hedge funds and large institutions have $177M invested in Surgalign Holdings, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

16% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 31

6% more funds holding

Funds holding: 103109 (+6)

9% less capital invested

Capital invested by funds: $193M → $177M (-$16.5M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
109
Holders Change
+6
Holders Change %
+5.83%
% of All Funds
2.47%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
18
Increased
36
Reduced
31
Closed
12
Calls
$88K
Puts
Net Calls
+$88K
Net Calls Change
-$142K
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
1
Paradigm Capital Management Inc
New York
$24.3M +$600K +4,368 +2%
BlackRock
2
BlackRock
New York
$20.1M -$465K -3,386 -2%
KAM
3
Krensavage Asset Management
New York
$17.8M -$361K -2,632 -2%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$17.5M +$674K +4,910 +4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$9.16M +$529K +3,854 +5%
HC
6
Hillman Company
Pennsylvania
$8.68M -$1.24M -9,060 -11%
RSCM
7
Rock Springs Capital Management
Maryland
$8M
Renaissance Technologies
8
Renaissance Technologies
New York
$5.38M +$402K +2,930 +7%
FP
9
Foundry Partners
Minnesota
$4.54M +$1.34M +9,744 +36%
State Street
10
State Street
Massachusetts
$4.51M +$40.9K +298 +0.8%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$4.03M +$46K +335 +1%
KIA
12
Kopp Investment Advisors
Minnesota
$3.71M -$238K -1,734 -5%
KCM
13
Kennedy Capital Management
Missouri
$3.17M -$35.6K -259 -1%
AL
14
AJO LP
Pennsylvania
$2.92M +$232K +1,691 +8%
Northern Trust
15
Northern Trust
Illinois
$2.75M -$18.5K -135 -0.6%
RA
16
Royce & Associates
New York
$2.58M
BCM
17
Bridgeway Capital Management
Texas
$2.45M +$399K +2,903 +17%
Millennium Management
18
Millennium Management
New York
$2.43M +$1.37M +9,951 +102%
RCM
19
Rutabaga Capital Management
Massachusetts
$2.28M -$3.68M -26,824 -59%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$2.04M +$44.4K +323 +2%
2L
21
22NW LP
Washington
$1.67M
Allianz Asset Management
22
Allianz Asset Management
Germany
$1.63M +$744K +5,418 +69%
WCM
23
Wedge Capital Management
North Carolina
$1.38M +$385K +2,807 +33%
AA
24
Ancora Advisors
Ohio
$1.15M +$88K +641 +7%
Victory Capital Management
25
Victory Capital Management
Texas
$1.04M +$221K +1,608 +23%

SRGA Hedge Fund Activity: Q4 2017 in Review

109 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2017, worth a combined $177M — down 8.5% from $193M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SRGA positions and 12 closed out — a net gain of 6 holders — while 36 added to existing stakes and 31 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.37M. The largest seller was Rutabaga Capital Management, cutting an estimated $3.68M.

  • 109 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2017, up from 103 in Q3 2017.
  • Funds reported $177M of Surgalign Holdings, Inc. Common Stock stock for Q4 2017, down 8.5% quarter-over-quarter.
  • 18 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2017 and 12 closed out, a net change of +6 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2017 was Millennium Management, an estimated $1.37M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2017 was Rutabaga Capital Management, an estimated $3.68M sold.

Based on aggregated 13F filings for Q4 2017.